🗓 16–17 February 2026 | 📍 Basel, SwitzerlandTheme: AI-Powered Pharmacovigilance: Humans in the Loop We’re excited to welcome experts, regulators, industry leaders, academics, and students for a 1.5-day in-person seminar exploring the latest developments in AI and pharmacovigilance. Why attend?✨ Engage with leading voices in AI, PV, and data science✨ Explore real-world applications and regulatory […]
SIGs
🌍 ISoP Pharmacovigilance in the Community SIG Initiative
Strengthening Medicine Safety Through Community Collaboration The latest Uppsala Reports article, “It Takes a Community to Make Medicines Safer for All,” highlights the crucial role of collaboration in improving medicine safety worldwide. This aligns with ISoP’s Special Interest Group (SIG) initiatives, which emphasize the power of collective efforts in pharmacovigilance. Discover how global partnerships and […]
ISoP Women’s Medicines SIG Now on LinkedIn!
We’re excited to announce that the ISoP Women’s Medicines Special Interest Group (SIG) now has a presence on LinkedIn! Join the group to connect, share insights, and stay updated on the latest discussions and activities related to women’s health and medicines. You can find the group at ISoP Women’s Medicines SIG on LinkedIn. Be sure […]
📢 Webinar Recording Now Available: Substandard and Falsified Medicines
Missed the ISoP webinar on Substandard and Falsified Medicines and Their Global Impact on January 16, 2025? Or want to revisit the insightful session? The recording is now available! 🎥 Where to Watch: This free webinar was the first of a three-part series, but note that the next two webinars will be exclusive to ISoP […]
GPPC Pilot Program Officially Launched!
As of 11 October 2024, we are excited to announce the official launch of the pilot phase of the Global PV Professional Certification (GPPC) program! This phase will thoroughly test all aspects before moving forward with the full certification for the initial roles. The pilot will focus on the PV Awareness test, which is our […]
Exciting Seminar Announcement: Unveiling the Role of Artificial Intelligence in Pharmacovigilance
We are pleased to announce that on 19 April at 10.00 Niklas Norén, chief science officer at the Uppsala Monitoring Center (Sweden), will present a seminar entitled “Artificial intelligence in Pharmacovigilance – value proposition and critical appraisal” at the University of Verona, introduced by Gianluca Trifirò. The seminar will be webcast at https://univr.zoom.us/j/95521455804 . The […]
